Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ:TELO

Biotechnology

Healthcare
$0.69 -3.42%

-$0.04 today

Market cap
$50.84M
Beta
-0.24
P/E (TTM)
-3.8
EPS (TTM)
-$0.27
52W Low $0.89High $2.09

Volume 0.17M

Average 0.13M

Balance Sheet

Inspect the capital base behind the business.

Assets

$7.34M

FY 2025 · Annual

+454.5% YoY

Liabilities

$1.43M

FY 2025 · Annual

+109.7% YoY

Equity

$5.91M

FY 2025 · Annual

+819.6% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents01.42K1.23K1.27M7.29M
Short-term Investments00000
Net Receivables00130K00
Inventory00000
Other Current Assets047.31K303.28K0(0)
Total Current Assets048.73K435.23K1.32M7.34M
Property, Plant & Equipment (Net)00000
Goodwill00000
Intangible Assets00000
Long-term Investments55K0000
Tax Assets00000
Other Non-current Assets004.34M00
Total Non-current Assets55K04.34M00
Total Assets55K48.73K4.77M1.32M7.34M
Account Payables18.74K404.22K707.19K587.54K536.77K
Short-term Debt0581.79K101K93.43K473.75K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities119.4K581.79K527.38K00
Total Current Liabilities138.13K986.01K1.34M680.97K1.43M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0(0)000
Total Non-current Liabilities0(0)000
Total Liabilities138.13K986.01K1.34M680.97K1.43M
Common Stock00000
Retained Earnings(138.13K)(992.28K)(14.06M)(30.6M)(41.01M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity(83.13K)(937.28K)3.44M643.04K5.91M
Total Debt0581.79K101K93.43K473.75K
Net Debt119.4K580.37K99.77K(1.17M)(6.81M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$5.6M
Other Current$229.0K
Total Current Assets$5.8M
Total Assets$5.8M

Analysis

Selected assets total $5.8M for Latest. The largest visible component is Cash & Equivalents at $5.6M, about 96.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
S-3S-3 filingOct 27, 2026
8-KCurrent reportOct 6, 2026
8-KCurrent reportSep 17, 2026
8-KCurrent reportSep 16, 2026
8-KCurrent reportSep 14, 2026

How much cash does TELO have?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) reported $7.29M in cash and equivalents in fiscal 2025.

How much debt does TELO carry?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) reported $473,752.00 of total debt, with net debt of -$6.81M.